European Heart Journal-Quality of Care and Clinical Outcomes

Papers
(The TQCC of European Heart Journal-Quality of Care and Clinical Outcomes is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs124
The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review117
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic56
Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry54
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary50
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews36
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease32
A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999–201827
Types of myocardial injury and mid-term outcomes in patients with COVID-1927
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines27
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis27
Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms26
The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)26
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation26
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study25
Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations25
Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation25
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines24
Temporal trends of mortality in patients with infective endocarditis: a nationwide study21
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry20
Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study20
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment20
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–201919
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrilla19
Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outc18
Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve17
Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials17
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 201917
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Progr17
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure17
Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation16
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re16
Gender differences in complications following catheter ablation of atrial fibrillation16
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction16
Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk16
Sex differences in mortality and 90-day readmission rates after transcatheter aortic valve replacement: a nationwide analysis from the USA16
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term exten16
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study15
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)15
Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)14
High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study14
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries14
Patient-reported outcome measures in cardiovascular disease13
Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials13
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies13
Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000–2013
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study13
Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry12
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)12
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?12
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk12
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland11
Alerting trends in epidemiology for calcific aortic valve disease, 1990–2019: An age–period–cohort analysis for the Global Burden of Disease Study 201911
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials11
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis11
The PRECISE-DAPT score and 5-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from China11
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice11
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom10
Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 201710
Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 201710
EURObservational Research Programme: a bibliometric assessment of its scientific output10
The association between cardiovascular disease admission rates and the coronavirus disease 2019 lockdown and reopening of a nation: a Danish nationwide cohort study10
Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 20199
Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection9
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries9
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis8
Critical Care Cardiology Trials Network (CCCTN): a cohort profile8
Potential for optimizing management of obesity in the secondary prevention of coronary heart disease8
The influence of the 2020 COVID-19 pandemic on the implantation rates of cardiac implantable electronic devices in Germany: changes between 2020 Q1–Q3 and 2019 Q1–Q38
Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I8
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 20408
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations8
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study8
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry8
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study8
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost–effectiveness and cost–utility analyses7
Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism7
Cost-effectiveness ofCYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes7
A hidden problem: peripheral artery disease in women7
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry7
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation7
Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics7
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) 7
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data7
Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis7
Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk7
The impact of atrial fibrillation on prognosis in aortic stenosis7
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study7
Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitation6
The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above: a Markov modelled analysis6
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus6
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analy6
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries6
Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome6
The association between urinary sodium concentration (UNa) and outcomes of acute heart failure: a systematic review and meta-analysis6
Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 20176
Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations6
Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study6
Diabetes mellitus and outcomes of lower extremity revascularization for peripheral artery disease6
The utility of implantable loop recorders in patient management: an age- and indication-stratified study in the outpatient-implant era6
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study6
Tuning and external validation of an adult congenital heart disease risk prediction model6
Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy6
0.04410195350647